Theophylline Tablet, Extended Release
Product Images NDC 42291-922

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Theophylline (NDC 42291-922). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100 (922 01)

Theophylline Extended-Release Tablets 300 mg by AvKARE. The label shows 100 tablets in the package with a red and black design on a white background. It includes standard storage and usage information, a barcode, QR code, and states the product is Rx only, manufactured in Pulaski, Tennessee.*

FDA Label Image

Structure (Structure)

Chemical structure of Theophylline, showing the molecular arrangement of atoms including carbon, nitrogen, oxygen, and hydrogen. The image also displays the molecular formula C7H8N4O2 and the molecular weight 180.17.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.